Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amin Hedayat

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Frontiers in Oncology|July 9, 2025
PD-1 monoclonal antibodies as an effective treatment for rare cutaneous malignancies: a case reportRyan Falk, Wolfram Samlowski, Amin Hedayat
Rare Tumors|May 19, 2026
Durable remission of metastatic myxoid liposarcoma following the cautious addition of pembrolizumab to ongoing pazopanib treatment: A case reportHussain Abbas, Wolfram Samlowski, Amin Hedayat
JAAD Case Reports|September 15, 2021
Atypical presentation of pediatric antiphospholipid syndromeHarrison Shawa, Amin Hedayat, David Cotter
Annals of Diagnostic Pathology|November 29, 2019
Enhanced cutaneous Rock2 expression as a marker of Rho Kinase pathway activation in autoimmune disease and Kohlemeier-Degos diseaseCynthia Magro, Ziv Schwartz, Jad Saab, et al.
Frontiers in Oncology|February 14, 2025
Case report: Complete response of recurrent locally advanced basal cell carcinoma following addition of vismodegib to neoadjuvant cemiplimab therapyChalette Lambert-Swainston, Wolfram Samlowski, Brandon Reynolds, et al.
Cutis|May 16, 2018
Painful violaceous nodule with peripheral hyperpigmentationBrian S Hoyt, Amin Hedayat, Robert E LeBlanc, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Frontiers in Oncology|July 9, 2025
PD-1 monoclonal antibodies as an effective treatment for rare cutaneous malignancies: a case reportRyan Falk, Wolfram Samlowski, Amin Hedayat
Rare Tumors|May 19, 2026
Durable remission of metastatic myxoid liposarcoma following the cautious addition of pembrolizumab to ongoing pazopanib treatment: A case reportHussain Abbas, Wolfram Samlowski, Amin Hedayat
JAAD Case Reports|September 15, 2021
Atypical presentation of pediatric antiphospholipid syndromeHarrison Shawa, Amin Hedayat, David Cotter
Annals of Diagnostic Pathology|November 29, 2019
Enhanced cutaneous Rock2 expression as a marker of Rho Kinase pathway activation in autoimmune disease and Kohlemeier-Degos diseaseCynthia Magro, Ziv Schwartz, Jad Saab, et al.
Frontiers in Oncology|February 14, 2025
Case report: Complete response of recurrent locally advanced basal cell carcinoma following addition of vismodegib to neoadjuvant cemiplimab therapyChalette Lambert-Swainston, Wolfram Samlowski, Brandon Reynolds, et al.
Cutis|May 16, 2018
Painful violaceous nodule with peripheral hyperpigmentationBrian S Hoyt, Amin Hedayat, Robert E LeBlanc, et al.
Pageof 1